Reducing Antibody Levels in Patients Undergoing Transplantation  

Oleh:

Shapiro, Ron

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 359 no. 03 (Jul. 2008), page 305.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2008.04 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

The advent of solid-organ transplantation for the treatment of patients with end-stage organ failure has been one of the most exciting medical advances in the late 20th and early 21st centuries. Thousands of lives have been saved or improved by transplantation, allowing terminally ill patients to rejoin society, work productively, and have a meaningful life.1,2 Unfortunately, transplantation has been an imperfect and expensive therapy. The financial burden of transplantation has limited its widespread application in the developed world; furthermore, therapeutic failure occurs all too often, owing to side effects or inadequacy of immunosuppression. Fortunately, in recent years, the potency of . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali